Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Azam, S, Lange, T, Huynh, S, Aro, AR, von Euler-Chelpin, M, Vejborg, I, Tjønneland, A, Lynge, E & Andersen, ZJ 2018, 'Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study' Cancer causes & control : CCC, bind 29, nr. 6, s. 495-505. https://doi.org/10.1007/s10552-018-1033-0

APA

Azam, S., Lange, T., Huynh, S., Aro, A. R., von Euler-Chelpin, M., Vejborg, I., ... Andersen, Z. J. (2018). Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study. Cancer causes & control : CCC, 29(6), 495-505. https://doi.org/10.1007/s10552-018-1033-0

CBE

Azam S, Lange T, Huynh S, Aro AR, von Euler-Chelpin M, Vejborg I, Tjønneland A, Lynge E, Andersen ZJ. 2018. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study. Cancer causes & control : CCC. 29(6):495-505. https://doi.org/10.1007/s10552-018-1033-0

MLA

Vancouver

Author

Azam, Shadi ; Lange, Theis ; Huynh, Stephanie ; Aro, Arja R ; von Euler-Chelpin, My ; Vejborg, Ilse ; Tjønneland, Anne ; Lynge, Elsebeth ; Andersen, Zorana J. / Hormone replacement therapy, mammographic density, and breast cancer risk : a cohort study. I: Cancer causes & control : CCC. 2018 ; Bind 29, Nr. 6. s. 495-505.

Bibtex

@article{879b3f6f1fd741ea884b347d19716050,
title = "Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study",
abstract = "PURPOSE: Hormone replacement therapy (HRT) use increases breast cancer risk and mammographic density (MD). We examine whether MD mediates or modifies the association of HRT with the breast cancer.METHODS: For the 4,501 participants in the Danish diet, cancer and health cohort (1993-1997) who attended mammographic screening in Copenhagen (1993-2001), MD (mixed/dense or fatty) was assessed at the first screening after cohort entry. HRT use was assessed by questionnaire and breast cancer diagnoses until 2012 obtained from the Danish cancer registry. The associations of HRT with MD and with breast cancer were analyzed separately using Cox's regression. Mediation analyses were used to estimate proportion [with 95{\%} confidence intervals (CI)] of an association between HRT and breast cancer mediated by MD.RESULTS: 2,444 (54.3{\%}) women had mixed/dense breasts, 229 (5.4{\%}) developed breast cancer, and 35.9{\%} were current HRT users at enrollment. Compared to never users, current HRT use was statistically significantly associated with having mixed/dense breasts (relative risk and 95{\%} CI 1.24; 1.14-1.35), and higher risk of breast cancer (hazard ratio 1.87; 1.40-2.48). Association between current HRT use and breast cancer risk was partially mediated by MD (percent mediated = 10{\%}; 95{\%} CI 4-22{\%}). The current HRT use-related breast cancer risk was higher in women with mixed/dense (1.94; 1.37-3.87) than fatty (1.37; 0.80-2.35) breasts (p value for interaction = 0.15).CONCLUSIONS: MD partially mediates some of the association between HRT and breast cancer risk. The association between HRT and breast cancer seems to be stronger in women with dense breasts.",
author = "Shadi Azam and Theis Lange and Stephanie Huynh and Aro, {Arja R} and {von Euler-Chelpin}, My and Ilse Vejborg and Anne Tj{\o}nneland and Elsebeth Lynge and Andersen, {Zorana J}",
year = "2018",
month = "6",
doi = "10.1007/s10552-018-1033-0",
language = "English",
volume = "29",
pages = "495--505",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "6",

}

RIS

TY - JOUR

T1 - Hormone replacement therapy, mammographic density, and breast cancer risk

T2 - a cohort study

AU - Azam, Shadi

AU - Lange, Theis

AU - Huynh, Stephanie

AU - Aro, Arja R

AU - von Euler-Chelpin, My

AU - Vejborg, Ilse

AU - Tjønneland, Anne

AU - Lynge, Elsebeth

AU - Andersen, Zorana J

PY - 2018/6

Y1 - 2018/6

N2 - PURPOSE: Hormone replacement therapy (HRT) use increases breast cancer risk and mammographic density (MD). We examine whether MD mediates or modifies the association of HRT with the breast cancer.METHODS: For the 4,501 participants in the Danish diet, cancer and health cohort (1993-1997) who attended mammographic screening in Copenhagen (1993-2001), MD (mixed/dense or fatty) was assessed at the first screening after cohort entry. HRT use was assessed by questionnaire and breast cancer diagnoses until 2012 obtained from the Danish cancer registry. The associations of HRT with MD and with breast cancer were analyzed separately using Cox's regression. Mediation analyses were used to estimate proportion [with 95% confidence intervals (CI)] of an association between HRT and breast cancer mediated by MD.RESULTS: 2,444 (54.3%) women had mixed/dense breasts, 229 (5.4%) developed breast cancer, and 35.9% were current HRT users at enrollment. Compared to never users, current HRT use was statistically significantly associated with having mixed/dense breasts (relative risk and 95% CI 1.24; 1.14-1.35), and higher risk of breast cancer (hazard ratio 1.87; 1.40-2.48). Association between current HRT use and breast cancer risk was partially mediated by MD (percent mediated = 10%; 95% CI 4-22%). The current HRT use-related breast cancer risk was higher in women with mixed/dense (1.94; 1.37-3.87) than fatty (1.37; 0.80-2.35) breasts (p value for interaction = 0.15).CONCLUSIONS: MD partially mediates some of the association between HRT and breast cancer risk. The association between HRT and breast cancer seems to be stronger in women with dense breasts.

AB - PURPOSE: Hormone replacement therapy (HRT) use increases breast cancer risk and mammographic density (MD). We examine whether MD mediates or modifies the association of HRT with the breast cancer.METHODS: For the 4,501 participants in the Danish diet, cancer and health cohort (1993-1997) who attended mammographic screening in Copenhagen (1993-2001), MD (mixed/dense or fatty) was assessed at the first screening after cohort entry. HRT use was assessed by questionnaire and breast cancer diagnoses until 2012 obtained from the Danish cancer registry. The associations of HRT with MD and with breast cancer were analyzed separately using Cox's regression. Mediation analyses were used to estimate proportion [with 95% confidence intervals (CI)] of an association between HRT and breast cancer mediated by MD.RESULTS: 2,444 (54.3%) women had mixed/dense breasts, 229 (5.4%) developed breast cancer, and 35.9% were current HRT users at enrollment. Compared to never users, current HRT use was statistically significantly associated with having mixed/dense breasts (relative risk and 95% CI 1.24; 1.14-1.35), and higher risk of breast cancer (hazard ratio 1.87; 1.40-2.48). Association between current HRT use and breast cancer risk was partially mediated by MD (percent mediated = 10%; 95% CI 4-22%). The current HRT use-related breast cancer risk was higher in women with mixed/dense (1.94; 1.37-3.87) than fatty (1.37; 0.80-2.35) breasts (p value for interaction = 0.15).CONCLUSIONS: MD partially mediates some of the association between HRT and breast cancer risk. The association between HRT and breast cancer seems to be stronger in women with dense breasts.

U2 - 10.1007/s10552-018-1033-0

DO - 10.1007/s10552-018-1033-0

M3 - Journal article

VL - 29

SP - 495

EP - 505

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 6

ER -

ID: 54645767